PA5-60948

antibody from Invitrogen Antibodies

Targeting: SSR4 TRAPD

Western blot (Supportive data in Antibodypedia)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

PA5-60948

Provider

Invitrogen Antibodies

Product name

SSR4 Polyclonal Antibody

Antibody type

Polyclonal

Antigen

Recombinant full-length protein

Description

Immunogen sequence: TPSYYTTSDA VISTETVFIV EISLTCKNRV QNMALYADVG GKQFPVTRGQ DVGRYQVSWS LDHKSAHAGT YEVRFFDEES YSLLRKAQRN NEDISIIPPL FTVSVDHRGT WNGPWVSTEV LAA

Concentration

0.05 mg/mL

Western blot

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Western blot analysis of SSR4 in Lane 1: Marker (kDa) 250, 130, 95, 72, 55, 36, 28, 17, 10; Lane 2: Human cell line RT-4; Lane 3: Human cell line U-251MG sp. Samples were probed using a SSR4 Polyclonal Antibody (Product # PA5-60948).

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Western blot analysis of SSR4 in Lane 1: NIH-3T3 cell lysate (Mouse embryonic fibroblast cells); Lane 2: NBT-II cell lysate (Rat Wistar bladder tumour cells). Samples were probed using a SSR4 Polyclonal Antibody (Product # PA5-60948).

Immunohistochemistry

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical staining of SSR4 in human pancreas and kidney tissues using SSR4 Polyclonal Antibody (Product # PA5-60948). Corresponding SSR4 RNA-seq data are presented for the same tissues.

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical staining of SSR4 in human pancreas using SSR4 Polyclonal Antibody (Product # PA5-60948) shows high expression.

Supportive validation

Submitted by

Invitrogen Antibodies (provider)

Main image

Experimental details

Immunohistochemical staining of SSR4 in human kidney using SSR4 Polyclonal Antibody (Product # PA5-60948) shows low expression as expected.